Dataset Information


Direct tandem mass spectrometric profiling of sulfatides in dry urinary samples for screening of metachromatic leukodystrophy.

ABSTRACT: Prediagnostic steps in suspected metachromatic leukodystrophy (MLD) rely on clinical chemical methods other than enzyme assays. We report a new diagnostic method which evaluates changes in the spectrum of molecular types of sulfatides (3-O-sulfogalactosyl ceramides) in MLD urine.The procedure allows isolation of urinary sulfatides by solid-phase extraction on DEAE-cellulose membranes, transportation of a dry membrane followed by elution and tandem mass spectrometry (MS/MS) analysis in the clinical laboratory. Major sulfatide isoforms are normalized to the least variable component of the spectrum, which is the indigenous C18:0 isoform. This procedure does not require the use of specific internal standards and minimizes errors caused by sample preparation and measurement.Urinary sulfatides were analyzed in a set of 21 samples from patients affected by sulfatidosis. The combined abundance of the five most elevated isoforms, C22:0, C22:0-OH, C24:0, C24:1-OH, and C24:0-OH sulfatides, was found to give the greatest distinction between MLD-affected patients and a control group.The method avoids transportation of liquid urine samples and generates stable membrane-bound sulfatide samples that can be stored at ambient temperature. MS/MS sulfatide profiling targeted on the most MLD-representative isoforms is simple with robust results and is suitable for screening.


PROVIDER: S-EPMC3806293 | BioStudies | 2013-01-01

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC4617137 | BioStudies
2014-01-01 | S-EPMC4039571 | BioStudies
1000-01-01 | S-EPMC4373750 | BioStudies
2016-01-01 | S-EPMC4737087 | BioStudies
2009-01-01 | S-EPMC4212524 | BioStudies
2012-01-01 | S-EPMC3413898 | BioStudies
1000-01-01 | S-EPMC4617136 | BioStudies
2020-01-01 | S-EPMC7266332 | BioStudies
2019-01-01 | S-EPMC6479561 | BioStudies
2013-01-01 | S-EPMC3924163 | BioStudies